As we take our prescription medications with little to no understanding of the intricate process behind getting them to market, it’s essential to shed light on the significant expenses and risks involved in developing new treatments. The pharmaceutical industry invests billions of dollars each year in research and development (R&D), yet the costs of clinical trials can be staggering.
The Expensive Process of Clinical Trials
Conducting clinical trials for a given medication typically takes years and requires substantial financial resources. In 2019, the pharmaceutical industry spent an estimated $83 billion on R&D. This astronomical amount is often too high for startups to manage, leading many to struggle financially as they navigate the approval process with the U.S. Food and Drug Administration (FDA).
The Rising Cost of Prescription Medications
According to Healthcare Finance, prescription medication prices have increased by approximately 35% since 2014. This surge in costs has sparked concern among healthcare professionals and patients alike. Adam Weisman, co-founder and CEO of startup Auxilius, believes that the expense of developing medications is a significant contributor to this trend.
"There are so many points of inefficiency in — and tax on — our systems…We’ve simply accepted this," he said in an interview. "And yet every other industry has developed increasingly sophisticated methods of predicting, managing, and pricing risk. I truly believe that if you want to manage prescription drug costs, you have to start at the beginning."
The Risk of Phase 3 Trial Failures
Sadly, some phase 3 trials fail due to lack of funding rather than safety or efficacy concerns regarding the treatment. This highlights the pressing need for more efficient and cost-effective approaches to managing clinical trials.
Introducing Auxilius: A Solution to Streamline Clinical Trials
Weisman’s startup, Auxilius, has developed an FP&A (financial planning & analysis) and accounting product designed to manage the complexity of clinical trials. Built from scratch, this platform aims to drive alignment between clinical and financial stakeholders, streamline core workflows, hold vendors accountable, and support audit, compliance, and reporting requirements.
Since its launch late last year, Auxilius has been in pilot with clinical trial sponsors managing 15 preclinical through phase 3 programs, 45 distinct vendors, and nearly $100 million in trial spending. The company expects its software to be deployed at 25 clients by the end of this year.
Renegade Partners Leads Funding Round
Auxilius recently secured $10 million in funding from Renegade Partners, with participation from existing backers Bain Capital Ventures and XYZ Venture Capital, as well as several angel investors. This investment will help the company advance its efforts to revolutionize the clinical trial process.
"We believe that Auxilius’ platform has the potential to transform the way biotech companies manage their clinical trials," said Roseanne Wincek, managing director at Renegade Partners. "The benefit of the Auxilius platform is immediately apparent to the biotech companies that now drive the majority of drug research and development."
A Ripple Effect: More ‘Lifesaving’ Therapies at Affordable Costs
Auxilius’ mission extends beyond helping biotechs manage financial aspects of clinical trials. Weisman envisions a future where more "lifesaving" therapies become available, at more affordable costs, as a result of the company’s efforts.
By streamlining clinical trials and reducing costs, Auxilius is poised to make a significant impact on the pharmaceutical industry. As the company continues to grow and develop its innovative platform, we can expect to see a ripple effect that benefits patients, healthcare professionals, and the industry as a whole.
Conclusion
The high cost of getting prescription medications to market is a pressing concern that requires attention from all stakeholders involved in the pharmaceutical industry. Auxilius’ pioneering approach to streamlining clinical trials offers a promising solution to this problem. With its innovative platform and commitment to reducing costs, the company is well-positioned to make a lasting impact on the industry.
Related Articles
- The High Cost of Prescription Medications: A Growing Concern
- The Importance of Efficient Clinical Trials in Developing New Treatments
- Revolutionizing Healthcare: The Role of Technology in Streamlining Clinical Trials
Subscribe to Our Newsletters
Stay up-to-date with the latest news and insights from TechCrunch by subscribing to our newsletters:
- TechCrunch Daily News: Receive the industry’s biggest tech news every weekday and Sunday.
- TechCrunch AI: Get coverage of the latest advancements in artificial intelligence, delivered weekly.
- Startups Weekly: Stay informed about the startup ecosystem with our weekly newsletter.
By submitting your email address, you agree to our Terms and Privacy Notice.
